Long-term outcomes in patients with Non Small Cell Lung Cancer (NSCLC) treated by Immune Checkpoint Inhibitors (ICIs) for a minimal duration of 2 years: a cohort study in a tertiary hospital.
S. Storme, L. Kiakouama, M. Darrason, G. Devouassoux, M. Duruisseaux, S. Couraud
{"title":"Long-term outcomes in patients with Non Small Cell Lung Cancer (NSCLC) treated by Immune Checkpoint Inhibitors (ICIs) for a minimal duration of 2 years: a cohort study in a tertiary hospital.","authors":"S. Storme, L. Kiakouama, M. Darrason, G. Devouassoux, M. Duruisseaux, S. Couraud","doi":"10.1183/13993003.congress-2022.603","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":229516,"journal":{"name":"11.01 - Lung cancer","volume":"84 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"11.01 - Lung cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2022.603","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
